Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 231

1.

Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.

Karlsen TH, Boberg KM, Vatn M, Bergquist A, Hampe J, Schrumpf E, Thorsby E, Schreiber S, Lie BA; IBSEN Study Group.

Genes Immun. 2007 Apr;8(3):275-8. Epub 2007 Feb 15.

PMID:
17301827
2.

MHC Class II alleles in ulcerative colitis-associated colorectal cancer.

Garrity-Park MM, Loftus EV Jr, Sandborn WJ, Bryant SC, Smyrk TC.

Gut. 2009 Sep;58(9):1226-33. doi: 10.1136/gut.2008.166686. Epub 2009 Feb 26.

PMID:
19251712
3.

Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.

Karlsen TH, Hampe J, Wiencke K, Schrumpf E, Thorsby E, Lie BA, Broomé U, Schreiber S, Boberg KM.

Am J Gastroenterol. 2007 Jan;102(1):115-21. Epub 2006 Nov 13.

PMID:
17100974
4.

HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations.

Spurkland A, Saarinen S, Boberg KM, Mitchell S, Broome U, Caballeria L, Ciusani E, Chapman R, Ercilla G, Fausa O, Knutsen I, Pares A, Rosina F, Olerup O, Thorsby E, Schrumpf E.

Tissue Antigens. 1999 May;53(5):459-69.

PMID:
10372541
5.

Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients.

Wiencke K, Louka AS, Spurkland A, Vatn M, Schrumpf E, Boberg KM; IBSEN Study Group.

J Hepatol. 2004 Aug;41(2):209-14.

PMID:
15288468
6.

Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes.

Wiencke K, Karlsen TH, Boberg KM, Thorsby E, Schrumpf E, Lie BA, Spurkland A.

Tissue Antigens. 2007 Feb;69(2):161-9.

PMID:
17257319
7.

HLA antigens in ulcerative colitis and primary sclerosing cholangitis.

Leidenius MH, Koskimies SA, Kellokumpu IH, Höckerstedt KA.

APMIS. 1995 Jul-Aug;103(7-8):519-24.

PMID:
7576567
8.

Combined HLA-DR and -DQ disparity is associated with a stable course of ulcerative colitis after liver transplantation for primary sclerosing cholangitis.

Cholongitas E, Papatheodoridis GV, Zappoli P, Giannakopoulos A, Patch D, Marelli L, Shusang V, Kalambokis G, Shirling G, Rolando N, Burroughs AK.

Liver Transpl. 2007 Apr;13(4):552-7.

9.

Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis.

Bergquist A, Montgomery SM, Bahmanyar S, Olsson R, Danielsson A, Lindgren S, Prytz H, Hultcrantz R, Lööf LA, Sandberg-Gertzén H, Almer S, Askling J, Ehlin A, Ekbom A.

Clin Gastroenterol Hepatol. 2008 Aug;6(8):939-43. doi: 10.1016/j.cgh.2008.03.016.

PMID:
18674735
10.

Association of primary sclerosing cholangitis, ulcerative colitis and coeliac disease in female siblings.

Habior A, Rawa T, Orłowska J, Sankowska M, Lewartowska A, Tilszer A, Pawlak J, Krawczyk M, Butruk E.

Eur J Gastroenterol Hepatol. 2002 Jul;14(7):787-91.

PMID:
12169991
11.
12.
13.

Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study.

Joo M, Abreu-e-Lima P, Farraye F, Smith T, Swaroop P, Gardner L, Lauwers GY, Odze RD.

Am J Surg Pathol. 2009 Jun;33(6):854-62. doi: 10.1097/PAS.0b013e318196d018.

PMID:
19295408
14.

HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis.

Olerup O, Olsson R, Hultcrantz R, Broome U.

Gastroenterology. 1995 Mar;108(3):870-8.

PMID:
7875491
15.

Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis.

Bowlus CL, Karlsen TH, Broomé U, Thorsby E, Vatn M, Schrumpf E, Lie BA, Boberg KM.

J Hepatol. 2006 Nov;45(5):704-10. Epub 2006 Apr 25.

PMID:
16750586
16.

Analysis of IL2/IL21 gene variants in cholestatic liver diseases reveals an association with primary sclerosing cholangitis.

Stallhofer J, Denk GU, Glas J, Laubender RP, Göke B, Rust C, Brand S, Pusl T.

Digestion. 2011;84(1):29-35. doi: 10.1159/000321619. Epub 2011 Feb 8.

PMID:
21304239
18.

The distribution of HLA-DRB alleles in ulcerative colitis patients in Turkey.

Uyar FA, Imeryüz N, Saruhan-Direskeneli G, Ceken H, Ozdoğan O, Sahin S, Tözün N.

Eur J Immunogenet. 1998 Aug;25(4):293-6.

PMID:
9777329
19.

HLA-DRB1 alleles influence clinical phenotypes in Japanese patients with ulcerative colitis.

Matsumura Y, Kinouchi Y, Nomura E, Negoro K, Kakuta Y, Endo K, Aizawa H, Takagi S, Takahashi S, Shimosegawa T.

Tissue Antigens. 2008 May;71(5):447-52. doi: 10.1111/j.1399-0039.2008.01031.x.

PMID:
18416774
20.

Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C.

Hov JR, Lleo A, Selmi C, Woldseth B, Fabris L, Strazzabosco M, Karlsen TH, Invernizzi P.

J Hepatol. 2010 May;52(5):712-7. doi: 10.1016/j.jhep.2009.11.029. Epub 2010 Mar 4.

PMID:
20347497

Supplemental Content

Support Center